A common TCR VDJ sequence in Vβ13. 1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis
J Hong, YCQ Zang, MV Tejada-Simon… - The Journal of …, 1999 - journals.aai.org
J Hong, YCQ Zang, MV Tejada-Simon, M Kozovska, S Li, RAK Singh, D Yang, VM Rivera…
The Journal of Immunology, 1999•journals.aai.orgT cell responses to the immunodominant peptide (residues 83–99) of myelin basic protein
are potentially associated with multiple sclerosis (MS). This study was undertaken to
examine whether a common sequence motif (s) exists within the TCR complementarity-
determining region (CDR)-3 of T cells recognizing the MBP83–99 peptide. Twenty MBP83–
99-reactive T cell clones derived from patients with MS were analyzed for CDR3 sequences,
which revealed several shared motifs. Some Vβ13. 1 T cell clones derived from different …
are potentially associated with multiple sclerosis (MS). This study was undertaken to
examine whether a common sequence motif (s) exists within the TCR complementarity-
determining region (CDR)-3 of T cells recognizing the MBP83–99 peptide. Twenty MBP83–
99-reactive T cell clones derived from patients with MS were analyzed for CDR3 sequences,
which revealed several shared motifs. Some Vβ13. 1 T cell clones derived from different …
Abstract
T cell responses to the immunodominant peptide (residues 83–99) of myelin basic protein are potentially associated with multiple sclerosis (MS). This study was undertaken to examine whether a common sequence motif (s) exists within the TCR complementarity-determining region (CDR)-3 of T cells recognizing the MBP83–99 peptide. Twenty MBP83–99-reactive T cell clones derived from patients with MS were analyzed for CDR3 sequences, which revealed several shared motifs. Some Vβ13. 1 T cell clones derived from different patients with MS were found to contain an identical CDR3 motif, Vβ13. 1-LGRAGLTY. Oligonucleotides complementary to the shared CDR3 motifs were used as specific probes to detect identical target CDR3 sequences in a large panel of T cell lines reactive to MBP83–99 and unprimed PBMC. The results revealed that, in contrast to other CDR3 motifs examined, the LGRAGLTY motif was common to T cells recognizing the MBP83–99 peptide, as evident by its expression in the majority of MBP83–99-reactive T cell lines (36/44) and PBMC specimens (15/48) obtained from randomly selected MS patients. The motif was also detected in lower expression in some PBMC specimens from healthy individuals, suggesting the presence of low precursor frequency of T cells expressing this motif in healthy individuals. This study provides new evidence indicating that the identified LGRAGLTY motif is preferentially expressed in MBP83–99-reactive T cells. The findings have important implications in monitoring and targeting MBP83–99-reactive T cells in MS.
journals.aai.org